ONCO MED-CHEMISTRY

dc.contributor.authorYusuphodjayeva Hurshida Sobirovna
dc.contributor.authorIslamova Zulfiyahon Saidg‘anihojanovna
dc.contributor.authorExecutor: Miraziz Muhammadiev Maksudovich
dc.date.accessioned2025-12-31T15:40:14Z
dc.date.issued2024-11-29
dc.description.abstractOnco Med-Chemistry focuses on designing and developing cancer therapies by integrating chemistry, biology, and pharmacology. It targets processes similarly carcinogenesis, tumor advancement, and drug resistance to create agents such as kinase inhibitors, immune checkpoint modulators, and antibody-drug conjugates. Tools like structure-based design and highthroughput screening are vital for innovation in this field.
dc.formatapplication/pdf
dc.identifier.urihttps://scholarexpress.net/index.php/wbph/article/view/4746
dc.identifier.urihttps://asianeducationindex.com/handle/123456789/49885
dc.language.isoeng
dc.publisherScholar Express Journals
dc.relationhttps://scholarexpress.net/index.php/wbph/article/view/4746/4025
dc.rightshttps://creativecommons.org/licenses/by-nc-nd/4.0
dc.sourceWorld Bulletin of Public Health; Vol. 40 (2024): WBPH; 91-92
dc.source2749-3644
dc.subjectoncology
dc.subjectmedicinal chemistry
dc.subjectcancer therapy
dc.titleONCO MED-CHEMISTRY
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion
dc.typePeer-reviewed Article

item.page.files

item.page.filesection.original.bundle

pagination.showing.labelpagination.showing.detail
loading.default
thumbnail.default.alt
item.page.filesection.name
sobirovna_2024_onco_med-chemistry.pdf
item.page.filesection.size
151.12 KB
item.page.filesection.format
Adobe Portable Document Format

item.page.collections